Nathalia Guarienti Missima, Henrik Hill, Casian-Simon Aioanei, Per Liss, Daniel Espes
{"title":"Alterations of the pancreas in type 1 diabetes - from prior to diagnosis to long-standing disease.","authors":"Nathalia Guarienti Missima, Henrik Hill, Casian-Simon Aioanei, Per Liss, Daniel Espes","doi":"10.1007/s12020-025-04338-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>In type 1 diabetes (T1D), the loss of insulin-producing beta-cells is the hallmark pathophysiological alteration. However, volumetric and functional abnormalities of the exocrine pancreas are also observed. These changes may result from the loss of insulin's anabolic effects or reflect an underexplored aspect of T1D. Imaging techniques have enabled a better characterization of pancreatic morphology throughout T1D progression. This study examines exocrine pancreatic alterations at various stages of T1D using CT scans, including assessments conducted prior to diagnosis.</p><p><strong>Methods: </strong>The study utilized retrospective abdominal CT scans and clinical data collected from Uppsala University Hospital, including 150 T1D subjects, with 15 examined before diagnosis, and 61 age- and gender-matched non-diabetic controls. Volume segmentation and 3D reconstruction assessed the exocrine pancreas, and pancreas volume index (PVI) calculations were standardized using body weight, BMI, and body surface area (BSA). Descriptive and laboratory data were obtained from electronic medical records.</p><p><strong>Results: </strong>Pancreas volume was significantly reduced in T1D patients. The reduction was more pronounced in patients diagnosed before the age of 20. No significant volume difference was noted in patients before their T1D diagnosis compared to controls, however, a reduction was observed post-diagnosis. Pancreas volume correlated negatively with disease duration and HbA1c levels and correlated positively with body surface area and plasma amylase levels.</p><p><strong>Conclusion: </strong>Pancreas volume reduction is a consistent feature in T1D, correlating with both disease duration and markers of metabolic control. These findings support the potential of using imaging techniques as a non-invasive method for monitoring T1D progression.</p>","PeriodicalId":49211,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04338-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: In type 1 diabetes (T1D), the loss of insulin-producing beta-cells is the hallmark pathophysiological alteration. However, volumetric and functional abnormalities of the exocrine pancreas are also observed. These changes may result from the loss of insulin's anabolic effects or reflect an underexplored aspect of T1D. Imaging techniques have enabled a better characterization of pancreatic morphology throughout T1D progression. This study examines exocrine pancreatic alterations at various stages of T1D using CT scans, including assessments conducted prior to diagnosis.
Methods: The study utilized retrospective abdominal CT scans and clinical data collected from Uppsala University Hospital, including 150 T1D subjects, with 15 examined before diagnosis, and 61 age- and gender-matched non-diabetic controls. Volume segmentation and 3D reconstruction assessed the exocrine pancreas, and pancreas volume index (PVI) calculations were standardized using body weight, BMI, and body surface area (BSA). Descriptive and laboratory data were obtained from electronic medical records.
Results: Pancreas volume was significantly reduced in T1D patients. The reduction was more pronounced in patients diagnosed before the age of 20. No significant volume difference was noted in patients before their T1D diagnosis compared to controls, however, a reduction was observed post-diagnosis. Pancreas volume correlated negatively with disease duration and HbA1c levels and correlated positively with body surface area and plasma amylase levels.
Conclusion: Pancreas volume reduction is a consistent feature in T1D, correlating with both disease duration and markers of metabolic control. These findings support the potential of using imaging techniques as a non-invasive method for monitoring T1D progression.
期刊介绍:
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.